Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

990
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
990
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

385
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
385
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

223
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
223
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

714
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
714
Cancer Survival Analysis01:21

Cancer Survival Analysis

630
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
630
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

538
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
538

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Accelerometer-Derived "Weekend Warrior" Physical Activity Pattern and Venous Thromboembolism Incidence and Mortality: A Prospective Cohort Study.

Journal of the American Heart Association·2026
Same author

Associations of insulin resistance-related indices with the risk and progression of cardiometabolic multimorbidity in individuals with metabolic dysfunction-associated steatotic liver disease: a prospective cohort study.

Cardiovascular diabetology·2026
Same author

Associations of chronic pain and genetic risks with incident atrial fibrillation: a prospective cohort study.

BMC cardiovascular disorders·2026
Same author

Associations of the atherogenic index of plasma and its modified indices with the incidence and progression of cardiovascular-liver-metabolic multimorbidity: a prospective cohort study from UK Biobank.

Cardiovascular diabetology·2026
Same author

Adherence to the EAT-Lancet Diet, plasma proteomics, and risk of venous thromboembolism: a large-scale prospective cohort study.

BMC medicine·2026
Same author

Plasma Multiomics Links Early-Life Adversity to Disease and Cardiometabolic Health: A Population-Based Cohort Study.

Journal of the American Heart Association·2026
Same journal

Covariance decomposition for distance based species tree estimation.

BMC bioinformatics·2026
Same journal

SNPio: a Python interface for population genomic data processing.

BMC bioinformatics·2026
Same journal

SpaHNR: a spatial domain identification method via sparse attention-based hierarchical node representation and multi-view contrastive learning.

BMC bioinformatics·2026
Same journal

OpenIMC: an open-source platform for analyzing single-cell and spatial proteomics by imaging mass cytometry.

BMC bioinformatics·2026
Same journal

NAP: an open source pipeline for cross-domain microbiome profiling using Nanopore sequencing-derived amplicon data.

BMC bioinformatics·2026
Same journal

SurvGME: an R package for survival analysis with graphical and measurement error models.

BMC bioinformatics·2026
查看所有相关文章

相关实验视频

Updated: Jan 9, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.2K

一个参数生存模型与贝叶斯结构方程基于多omics集成的参数生存模型.

Jiadong Chu1, Yu Wang1,2, Na Sun3

  • 1Department of Epidemiology and Biostatistics, School of Public Health, Medical College of Soochow University, Suzhou, 215123, China.

BMC bioinformatics
|November 29, 2025
PubMed
概括
此摘要是机器生成的。

这项研究介绍了一种先进的贝叶斯结构方程模型,用于多omics生存分析. 这种新的框架通过整合各种omics数据来改善瘤发育预测,优于现有的方法.

关键词:
贝叶斯的框架 贝叶斯的框架癌症 癌症 癌症 癌症多个omics的多个omics.结构方程模型的结构方程模型.预测生存的预测.

更多相关视频

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.0K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

相关实验视频

Last Updated: Jan 9, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.2K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

2.0K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

科学领域:

  • 在瘤学瘤学.
  • 生物信息学是一种生物信息学.
  • 统计建模 统计建模

背景情况:

  • 多omics集成提供了关于瘤发育和预测建模的见解.
  • 整合多样化的OMIC数据,特别是捕捉生物关系,仍然是一个挑战.
  • 现有的结构方程模型在生存预测的多omics集成方面存在局限性.

研究的目的:

  • 开发一个扩展的贝叶斯生存模型,与多omics数据的结构方程模型集成.
  • 改进多个omics源的整合,以提高癌症研究中的预测准确度.
  • 为了解决以前的模型在捕捉复杂的生物关系的局限性.

主要方法:

  • 开发了一个扩展的贝叶斯生存模型与结构方程模型相结合.
  • 无U转取样 (NUTS) 算法用于高效的后部分布采样.
  • 该模型使用胃癌数据集与mRNA,microRNA和甲基化数据进行了验证.

主要成果:

  • 拟议的模型在模拟中展示了出色的适合性和预测性能.
  • 与非集成模型相比,对胃癌数据集的应用显示出优异的预测性能.
  • 该模型在多omics生存分析中表现优于综合贝叶斯基因组学分析 (iBAG) 模型.

结论:

  • 扩展的贝叶斯结构方程模型为多omics生存分析提供了一个强大的框架.
  • 该模型通过捕捉跨欧米克数据的复杂生物关系,显著提高了预测准确性.
  • 这种方法在非集成方法和现有的集成技术 (如iBAG) 上显示了明显的优势.